Paolo D’Arrigo

929 total citations
24 papers, 532 citations indexed

About

Paolo D’Arrigo is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Paolo D’Arrigo has authored 24 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Paolo D’Arrigo's work include CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers) and Signaling Pathways in Disease (5 papers). Paolo D’Arrigo is often cited by papers focused on CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers) and Signaling Pathways in Disease (5 papers). Paolo D’Arrigo collaborates with scholars based in Italy, Belgium and Sweden. Paolo D’Arrigo's co-authors include Maria Fiammetta Romano, Simona Romano, Sergio Buccheri, Davide Capodanno, Martina Tufano, Corrado Tamburino, Marco Barbanti, Giuseppe Venuti, Stefania Staibano and Antonio Condorelli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Current Medicinal Chemistry.

In The Last Decade

Paolo D’Arrigo

23 papers receiving 520 citations

Peers

Countries citing papers authored by Paolo D’Arrigo

Since Specialization

Citations

This map shows the geographic impact of Paolo D’Arrigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo D’Arrigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo D’Arrigo more than expected).

Fields of papers citing papers by Paolo D’Arrigo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo D’Arrigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo D’Arrigo. The network helps show where Paolo D’Arrigo may publish in the future.

Co-authorship network of co-authors of Paolo D’Arrigo

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo D’Arrigo. A scholar is included among the top collaborators of Paolo D’Arrigo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo D’Arrigo. Paolo D’Arrigo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploring the potential of selective FKBP51 inhibitors on melanoma: an investigation of their in vitro and in vivo effects 2025 ·Cell Death Discovery ·Laura Marrone, Valeria Di Giacomo, (unknown), (unknown), Felix Hausch, (unknown), (unknown), Martina Tufano, Paolo D’Arrigo, Maria Fiammetta Romano, Simona Romano	0
2	Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: A proof of principle 2022 ·Molecular Therapy — Oncolytics ·(unknown), (unknown), Virginie Neirinckx, Arnaud Lombard, Natacha Coppieters, Paolo D’Arrigo, (unknown), (unknown), Benoît Brouwers, (unknown), Bernard Rogister, Marielle Lebrun, Catherine Sadzot‐Delvaux	10
3	Determinants of Popularity and Natural History of Social Media Accounts in Interventional Cardiology 2021 ·JACC: Cardiovascular Interventions ·Paolo D’Arrigo, Antonio Greco, (unknown), (unknown), (unknown), (unknown), Federica Agnello, (unknown), Giovanni Occhipinti, Lorenzo Scalia, Marco Spagnolo, Davide Capodanno	3
4	Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation 2020 ·EuroIntervention ·Giuliano Costa, Marco Barbanti, Andrea Picci, Denise Todaro, (unknown), Emanuela Di Simone, Paolo D’Arrigo, Enrico Criscione, Roberto Valvo, Claudia Reddavid, Wanda Deste, Carmelo Sgroi, Corrado Tamburino, Angelo Giuffrida, (unknown), (unknown), (unknown), (unknown), Pierfrancesco Veroux	23
5	Mechanisms of ST-segment elevation myocardial infarction in patients with atrial fibrillation, prior stenting and long-standing chronic coronary syndrome 2020 ·Cardiology Journal ·(unknown), (unknown), Paolo D’Arrigo, (unknown), (unknown), Antonio Greco, Marco Spagnolo, Corrado Tamburino, Davide Capodanno	4
6	Outcomes of renin–angiotensin–aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis 2020 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Antonio Greco, Sergio Buccheri, Paolo D’Arrigo, (unknown), Federica Agnello, (unknown), (unknown), (unknown), (unknown), Davide Capodanno	15
7	Cell stemness, epithelial-to-mesenchymal transition, and immunoevasion: Intertwined aspects in cancer metastasis 2019 ·Seminars in Cancer Biology ·Simona Romano, Martina Tufano, Paolo D’Arrigo, (unknown), Salvatore Russo, Maria Fiammetta Romano	32
8	The splicing FK506-binding protein-51 isoform plays a role in glioblastoma resistance through programmed cell death ligand-1 expression regulation 2019 ·Cell Death Discovery ·Paolo D’Arrigo, Marina Digregorio, Simona Romano, Martina Tufano, (unknown), Felix Hausch, Matthias Dedobbeleer, (unknown), Salvatore Russo, Michael Bauder, Bernard Rogister, Maria Fiammetta Romano	16
9	Risk Stratification in Patients with Coronary Artery Disease: a Practical Walkthrough in the Landscape of Prognostic Risk Models 2018 ·Interventional Cardiology Reviews Research Resources ·Sergio Buccheri, Paolo D’Arrigo, (unknown), Davide Capodanno	22
10	Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules 2018 ·Current Medicinal Chemistry ·Paolo D’Arrigo, Martina Tufano, (unknown), (unknown), (unknown), Salvatore Russo, Maria Fiammetta Romano, Simona Romano	17
11	Early and Mid-Term Outcomes of Transcatheter Aortic Valve Replacement Using the New Generation Self-Expanding Corevalve Evolut R Device 2018 ·Structural Heart ·Denise Todaro, Marco Barbanti, Andrea Picci, Giuliano Costa, Emanuela Di Simone, Simona Gulino, Piera Capranzano, Gerlando Pilato, (unknown), Wanda Deste, (unknown), Daniela Giannazzo, Paolo D’Arrigo, (unknown), Davide Capodanno, Sebastiano Immè, Claudia Tamburino, Martina Patanè, Carmelo Sgroi, Corrado Tamburino	1
12	TRAF2 and FKBP51 as possible markers for identification of suitable melanoma tumors for tumor necrosis factor-α inhibition 2018 ·Melanoma Research ·Simona Romano, Paolo D’Arrigo, Martina Tufano, Stefania Staibano, (unknown), Francesco Merolla, Gennaro Ilardi, Antonello Petrella, Maria Fiammetta Romano	3
13	Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography–Guided Percutaneous Coronary Intervention With Stent Implantation 2017 ·JACC: Cardiovascular Interventions ·Sergio Buccheri, (unknown), (unknown), (unknown), Giuseppe Venuti, Paolo D’Arrigo, Bruno Francaviglia, (unknown), Antonio Condorelli, Marco Barbanti, Piera Capranzano, Corrado Tamburino, Davide Capodanno	161
14	FKBP51s signature in peripheral blood mononuclear cells of melanoma patients as a possible predictive factor for immunotherapy 2017 ·Cancer Immunology Immunotherapy ·Simona Romano, Ester Simeone, (unknown), Paolo D’Arrigo, Michele Russo, Mario Capasso, Vito Alessandro Lasorsa, Nicola Zambrano, Paolo A. Ascierto, Maria Fiammetta Romano	13
15	A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma 2017 ·Oncotarget ·Paolo D’Arrigo, Michele Russo, (unknown), Martina Tufano, Elia Guadagno, Marialaura Del Basso De, Roberto Pacelli, Felix Hausch, Stefania Staibano, Gennaro Ilardi, Silvia Parisi, Maria Fiammetta Romano, Simona Romano	81
16	Expansion of a lymphocyte subset expressing a spliced FKBP51 isoform in melanoma patients. 2015 ·Journal of Clinical Oncology ·(unknown), (unknown), Paolo A. Ascierto, Ester Simeone, Stefania Staibano, Paolo D’Arrigo, Michele Russo, Rita Bisogni, Simona Romano	1
17	Immunomodulatory pathways regulate expression of a spliced FKBP51 isoform in lymphocytes of melanoma patients 2015 ·Pigment Cell & Melanoma Research ·Simona Romano, (unknown), Stefania Staibano, Ester Simeone, Paolo D’Arrigo, Paolo A. Ascierto, Massimiliano Scalvenzi, Massimo Mascolo, Gennaro Ilardi, Francesco Merolla, (unknown), Maria Fiammetta Romano	26
18	Tirofiban induces VEGF production and stimulates migration and proliferation of endothelial cells 2014 ·Vascular Pharmacology ·Arturo Giordano, (unknown), Simona Romano, Paolo D’Arrigo, Nicola Corcione, Rita Bisogni, (unknown), (unknown), Paolo Pepino, Paolo Ferraro, Maria Fiammetta Romano	32
19	FKBP51 increases the tumour‐promoter potential of TGF‐beta 2014 ·Clinical and Translational Medicine ·Simona Romano, (unknown), Paolo D’Arrigo, Stefania Staibano, Adelaide Greco, Arturo Brunetti, Massimiliano Scalvenzi, Rita Bisogni, Iris Scala, Maria Fiammetta Romano	30
20	The Protein Factory 2014 ·IrInSubria (University of Insubria) ·(unknown), Flavia Marinelli, Loredano Pollegioni, Gabriele Candiani, Paolo D’Arrigo, Süleyman Servi, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact